F.D.A. Panel Recommends Booster for Many Moderna Vaccine Recipients
By BY SHARON LAFRANIERE AND NOAH WEILAND
U.S.
https://ift.tt/3vkVf8v
Those eligible for the extra shot would include adults over 65 and others at high risk — the same groups now eligible for a Pfizer-BioNTech boost
New York Times
Vaccination and Immunization, Drugs (Pharmaceuticals), Coronavirus (2019-nCoV)
October 14, 2021 at 11:41PM